{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"postural-orthostatic-tachycardia-syndrome-due-to-net-deficiency","columns":[{"gene":"","key":"population-bb3171a0cdf913994620","label":"Orthostatic intolerance","mondoId":"MONDO:0011479","onsetQualifier":null,"originColumnKey":"MONDO:0011479/OMIM:604715","originalViews":[{"key":"MONDO:0011479/OMIM:604715","label":"Orthostatic intolerance","scopeLabel":"OMIM:604715","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["f34fb6f8ef2afe870d29f34976c7f23a5f4182cf49f8966380d69e0947d569d7","f866fb7d8e21c47c596cbfc94460396aa35ec68ea277591476b0af2ca1ab38f6"],"recordQualifiers":{},"scopeLabel":"OMIM:604715","sourceIds":["OMIM:604715"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-bb3171a0cdf913994620"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0003345","HP:0012173"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":2,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":2,"sourceGroups":{"published":2}},"features":[{"hpoId":"HP:0003345","label":"Elevated urinary norepinephrine level","primary":true},{"hpoId":"HP:0012173","label":"Orthostatic tachycardia","primary":true}],"ledeHtml":"A rare, genetic, primary orthostatic disorder caused by the impaired clearance of neurotransmitters at the synaptic cleft due to the deficiency of norepinephrine transporters (NET), characterized by dizziness, palpitations, fatigue, blurred vision and tachycardia following postural change from a supine to an upright position, in the absence of hypotension. A syncope with transient cognitive impairment and dyspnea may also occur. The norepinephrine transporter deficiency leads to abnormal uptake and high plasma concentrations of norepinephrine.","mondoId":"MONDO:0011479","node":{"canonicalSlug":"postural-orthostatic-tachycardia-syndrome-due-to-net-deficiency","comparisons":[{"documentSha256":"fb74bab6841b8f38b088893c18d54a7218ecd8f406fe1356f8bdc167c2874951","key":"legacy-postural-orthostatic-tachycardia-syndrome-due-to-net-deficiency","kind":"legacy","label":"postural orthostatic tachycardia syndrome due to NET deficiency","memberIds":["MONDO:0011479"],"mondoId":"MONDO:0011479","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/postural-orthostatic-tachycardia-syndrome-due-to-net-deficiency.fb74bab6841b8f38b088893c18d54a7218ecd8f406fe1356f8bdc167c2874951.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"postural orthostatic tachycardia syndrome due to NET deficiency","paragraphs":["A rare, genetic, primary orthostatic disorder caused by the impaired clearance of neurotransmitters at the synaptic cleft due to the deficiency of norepinephrine transporters (NET), characterized by dizziness, palpitations, fatigue, blurred vision and tachycardia following postural change from a supine to an upright position, in the absence of hypotension. A syncope with transient cognitive impairment and dyspnea may also occur. The norepinephrine transporter deficiency leads to abnormal uptake and high plasma concentrations of norepinephrine."],"scope":"exact","source":"MONDO","upstream":"https://orcid.org/0000-0002-7638-4659, Orphanet:443236, PMID:34928881","url":"https://monarchinitiative.org/MONDO:0011479"},"ownColumnKeys":["population-bb3171a0cdf913994620"],"publication":"published","relationships":[{"kind":"parent","label":"heart conduction disease","mondoId":"MONDO:0000992","slug":null},{"kind":"parent","label":"orthostatic intolerance","mondoId":"MONDO:0001315","slug":null},{"kind":"parent","label":"hereditary neurological disease","mondoId":"MONDO:0100545","slug":null},{"kind":"parent","label":"cardiogenetic disease","mondoId":"MONDO:0100547","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Name scope not exact or reviewed","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/13591"}],"translation":"pending"},"records":[{"frequencyKind":"count","key":"f34fb6f8ef2afe870d29f34976c7f23a5f4182cf49f8966380d69e0947d569d7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:604715","disease_name":"Orthostatic intolerance","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0012173","is_excluded":false,"label":"Orthostatic tachycardia","onset_id":null,"reference":"PMID:10684912","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f866fb7d8e21c47c596cbfc94460396aa35ec68ea277591476b0af2ca1ab38f6","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:604715","disease_name":"Orthostatic intolerance","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0003345","is_excluded":false,"label":"Elevated urinary norepinephrine level","onset_id":null,"reference":"PMID:10684912","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011479\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>https://orcid.org/0000-0002-7638-4659, Orphanet:443236, PMID:34928881</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare, genetic, primary orthostatic disorder caused by the impaired clearance of neurotransmitters at the synaptic cleft due to the deficiency of norepinephrine transporters (NET), characterized by dizziness, palpitations, fatigue, blurred vision and tachycardia following postural change from a supine to an upright position, in the absence of hypotension. A syncope with transient cognitive impairment and dyspnea may also occur. The norepinephrine transporter deficiency leads to abnormal uptake and high plasma concentrations of norepinephrine.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011479\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"postural-orthostatic-tachycardia-syndrome-due-to-net-deficiency","sourceDocuments":[{"name":"MONDO: postural orthostatic tachycardia syndrome due to NET deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0011479"}],"sourceNote":"","synonyms":["familial orthostatic tachycardia due to norepinephrine transporter deficiency","orthostatic intolerance due to NET deficiency","postural orthostatic tachycardia syndrome due to NET deficiency"],"takeawayHtml":"","title":"postural orthostatic tachycardia syndrome due to NET deficiency"},"schemaVersion":1}
